| 000 | 01663 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250518003346.0 | ||
| 264 | 0 | _c20191025 | |
| 008 | 201910s 0 0 eng d | ||
| 022 | _a1873-2364 | ||
| 024 | 7 |
_a10.1016/j.nmd.2018.07.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMcDonald, Craig M | |
| 245 | 0 | 0 |
_aLongitudinal pulmonary function testing outcome measures in Duchenne muscular dystrophy: Long-term natural history with and without glucocorticoids. _h[electronic resource] |
| 260 |
_bNeuromuscular disorders : NMD _c11 2018 |
||
| 300 |
_a897-909 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aGlucocorticoids _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMuscular Dystrophy, Duchenne _xdrug therapy |
| 650 | 0 | 4 | _aRespiratory Function Tests |
| 650 | 0 | 4 | _aSpirometry |
| 650 | 0 | 4 | _aVital Capacity |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aGordish-Dressman, Heather | |
| 700 | 1 | _aHenricson, Erik K | |
| 700 | 1 | _aDuong, Tina | |
| 700 | 1 | _aJoyce, Nanette C | |
| 700 | 1 | _aJhawar, Sanjay | |
| 700 | 1 | _aLeinonen, Mika | |
| 700 | 1 | _aHsu, Fengming | |
| 700 | 1 | _aConnolly, Anne M | |
| 700 | 1 | _aCnaan, Avital | |
| 700 | 1 | _aAbresch, Richard T | |
| 773 | 0 |
_tNeuromuscular disorders : NMD _gvol. 28 _gno. 11 _gp. 897-909 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.nmd.2018.07.004 _zAvailable from publisher's website |
| 999 |
_c28954616 _d28954616 |
||